Ma Lili
180 Fenglin Road
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study.
Journal: Arthritis research & therapy
Published: February 03, 2023
Clinical and pathological predictors of relapse in IgG4-related disease.
Journal: Arthritis research & therapy
Published: June 30, 2021
Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension.
Journal: Arthritis research & therapy
Published: May 13, 2021
Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry.
Journal: Therapeutic advances in chronic disease
Published: April 12, 2021
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis.
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis.
Journal: Modern rheumatology
Published: January 26, 2021
Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.
Journal: Clinical rheumatology
Published: September 17, 2020
Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study.
Journal: Therapeutic advances in musculoskeletal disease
Published: March 15, 2020
In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease.
Journal: Frontiers in immunology
Published: January 10, 2020
Endoscopic Cyanoacrylate Injection with Lauromacrogol for Gastric Varices: Long-Term Outcomes and Predictors in a Retrospective Cohort Study.
Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
Published: July 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026